Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*
Launched by SHRINERS HOSPITALS FOR CHILDREN · Mar 4, 2024
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying children who have a condition called Idiopathic Toe Walking (ITW), which means they walk on their toes without a known medical reason. The goal of the trial is to compare two types of treatments: non-operative treatment using casting and surgical treatment. Researchers want to see how well each treatment works by looking at how children walk and how their parents feel about the outcomes. Additionally, the study aims to find out if there are specific genes that might be linked to this condition.
To participate in the trial, children must be between 6 and 18 years old and have a diagnosis of persistent Idiopathic Toe Walking. They should also have certain measurements related to their ankle movement. However, children with autism or any other conditions that could affect their walking due to muscle or nerve issues can't take part in the study. If eligible, participants can expect to receive one of the two treatments and be closely monitored to track their progress. This research is important as it may help improve future treatments for children with ITW.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosis of Idiopathic Toe Walking Persistent (ITWp)
- • 2. Between the ages of 6-18 years
- • 3. Passive dorsiflexion dorsiflexion with knee extension between -10 plantar flexion - + 5 degrees of dorsiflexion, DiGiovanni defined an isolated gastrocnemius contracture as maximum passive ankle dorsiflexion as \< 5 degrees with the knee in full extension
- Exclusion Criteria:
- • 1. Diagnosis of Autism or autism spectrum disorder
- • 2. Presence of any indicators of trauma, neuromuscular influence or neurogenic influence as identified by using the Toe Walking Tool
About Shriners Hospitals For Children
Shriners Hospitals for Children is a renowned nonprofit organization dedicated to providing specialized pediatric care and advancing medical research. With a network of hospitals across North America, Shriners Hospitals focuses on treating children with complex orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate, regardless of the family's ability to pay. Committed to improving the quality of life for children, the institution actively engages in clinical trials to explore innovative treatments and therapies, fostering advancements in pediatric medicine and ensuring the highest standards of care for its young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Greenville, South Carolina, United States
Sacramento, California, United States
Portland, Oregon, United States
Chicago, Illinois, United States
Salt Lake City, Utah, United States
Lexington, Kentucky, United States
Spokane, Washington, United States
Patients applied
Trial Officials
Jeremy Bauer, MD
Principal Investigator
Shriners Hospitals for Children-Portland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported